Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 01, 2025 09:00 ET | Source: Medical Microinstruments, Inc.

MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential

MMI, today announced that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT®) code for lymphovenous bypass.
December 01, 2025 07:00 ET | Source: NeurAxis, Inc.

NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain

CARMEL, Ind., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
November 26, 2025 07:29 ET | Source: Research and Markets

Medical Device Collaboration and Licensing Agreements Trends Analysis Report 2025 with Directory of 903 Deals Signed Since 2016 by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Medical Device Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
November 24, 2025 01:30 ET | Source: ONWARD Medical NV

ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025

EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement,...
November 18, 2025 13:38 ET | Source: PrognomiQ

UPDATE – PrognomiQ Launches ProVue Lung, a Proteomics-Based Laboratory Developed Test to Aid in the Early Detection of Lung Cancer

PrognomiQ launches ProVue Lung, a novel proteomics-based Laboratory Developed Test (LDT) to help improve detection of lung cancer at its earliest stages.
November 17, 2025 01:30 ET | Source: ONWARD Medical NV

ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US FDA clearance now allows use of the ARC-EX® System both in...
November 12, 2025 17:07 ET | Source: kneat.com, inc.

Kneat Announces Record Revenue for Third Quarter 2025

Kneat's market leadership continues, with Q3 2025 YoY growth in ARR of 37% to $68.6 million and in SaaS revenue of 33% to $15.2 million.
November 12, 2025 08:00 ET | Source: NeurAxis, Inc.

NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives

CARMEL, Ind., Nov. 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
November 11, 2025 07:00 ET | Source: NeurAxis, Inc.

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

CARMEL, Ind., Nov. 11, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for...
November 10, 2025 09:17 ET | Source: Research and Markets

Biopsy Devices Market: Key Players Analysis Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts

Dublin, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The "Biopsy Devices Market: Key Players Analysis Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and...